Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.
Saturday, August 29, 2026
Search covers the most recently published. For the full archive, browsethe topics.
3 results for"Cardinal Health"
Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.
The Jackets will host the Louisville Cardinals for their ninth game of the 2026 campaign, and to many, the matchup doesn’t make the shortlist of the season’s...
Gaza’s Health Ministry reports rising casualties amid escalated Israeli attacks, with victims trapped under rubble.